Bayesian Capital Management, LP Ionis Pharmaceuticals Inc Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $712,802 - $874,552	21,227 New	21,227 $758,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $287,387 - $389,709	9,063 New	9,063 $336,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $248,305 - $323,565	-5,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $75,504 - $115,071	1,815 Added 52.08%	5,300 $251,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $187,667 - $227,465	3,485 New	3,485 $211,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.